AK

Arunachalam Kannappan

Active Director Director DIN 02863780
DIN 02863780 First appointment Mar 1985 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 1985
Shareholding value β€’β€’β€’β€’ Premium profile

About Arunachalam Kannappan

Data last updated:

Arunachalam Kannappan is a Director at Meirs Pharma (India) Private Limited (since 1985). The company operates in Healthcare.

DIN 02863780
Primary Designation Director
Industry Healthcare
First Appointment 27 Mar 1985
Oldest Company Age 41 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meirs Pharma (India) Private Limited U24305PY1985PTC000311
Director27 Mar 19851985Active

Directorship timeline

Open interactive timeline →
Meirs Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Arunachalam Kannappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arunachalam Kannappan

Arunachalam Kannappan currently holds 1 directorship: Meirs Pharma (India) Private Limited (Director, since 27 Mar 1985).

Arunachalam Kannappan was first appointed on 27 Mar 1985 as Director at Meirs Pharma (India) Private Limited.

The current boards of Arunachalam Kannappan's companies include Bairavan Ramasamy Chettiar (Meirs Pharma (India) Private Limited), Bhupendra Kumar Nirula (Meirs Pharma (India) Private Limited), Ramaswamy Bairavan (Meirs Pharma (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available